| |
| |
|
| Insider
Information: |
Versant Venture Capital V (canada), Lp |
| Relationship: |
|
| City: |
San Francisco |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
12,670 |
|
|
Indirect Shares
|
341,670 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$16,032,444 |
|
|
| Total
Shares |
354,340 |
|
|
| Total
Value |
$16,032,444 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Crispr Therapeutics Ag |
CRSP |
10% Owner |
2016-10-24 |
0 |
2018-04-24 |
115,645 |
Premium* |
|
|
Crinetics Pharmaceuticals, Inc. |
CRNX |
10% Owner |
2018-07-20 |
0 |
2018-07-20 |
226,025 |
Premium* |
|
|
Aprea Therapeutics, Inc. |
APRE |
|
2019-10-02 |
12,670 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
9 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| APRE |
Aprea Therapeutics, Inc. |
|
– – • |
2019-10-02 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
12,670 |
|
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
– – • |
2018-07-20 |
4 |
A |
$0.00 |
$0 |
I/I |
3,384,276 |
226,025 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
10% Owner |
– – • |
2018-04-24 |
4 |
AS |
$50.60 |
$1,164,655 |
I/I |
(22,841) |
115,645 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
10% Owner |
– – • |
2018-04-23 |
4 |
AS |
$50.66 |
$5,168,901 |
I/I |
(101,994) |
117,173 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
10% Owner |
– – • |
2018-04-20 |
4 |
A |
$0.00 |
$0 |
I/I |
92,918 |
92,918 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
10% Owner |
– – • |
2018-04-20 |
4 |
AS |
$0.00 |
$0 |
I/I |
(592,918) |
0 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
10% Owner |
– – • |
2016-10-24 |
4 |
A |
$14.00 |
$2,254,000 |
I/I |
161,000 |
185,987 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
10% Owner |
– – • |
2016-10-24 |
4/A |
B |
$14.00 |
$2,254,000 |
I/I |
161,000 |
185,987 |
1.5 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
10% Owner |
– – • |
2016-10-24 |
4/A |
A |
$0.00 |
$0 |
I/I |
6,508,699 |
79,478 |
0 |
- |
|
9 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
